4//SEC Filing
Alam Kamran 4
Accession 0001209191-23-033681
CIK 0001806310other
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 4:12 PM ET
Size
5.2 KB
Accession
0001209191-23-033681
Insider Transaction Report
Form 4
Alam Kamran
CHIEF FINANCIAL OFFICER
Transactions
- Award
Common Stock
2023-05-31+6,230→ 291,042 total
Footnotes (2)
- [F1]Represents a performance restricted stock unit ("PRSU") award. The PRSUs were awarded on February 2, 2023 by the Compensation Committee (the "Compensation Committee") of the Issuer's Board of Directors as annual incentive compensation for 2022 performance. On May 31, 2023, the Compensation Committee certified the achievement of a certain performance goal. The PRSUs covered by this report vested upon certification.
- [F2]Each PRSU represented a contingent right to receive one share the Issuer's common stock.
Documents
Issuer
Taysha Gene Therapies, Inc.
CIK 0001806310
Entity typeother
Related Parties
1- filerCIK 0001793412
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 4:12 PM ET
- Size
- 5.2 KB